NECFA
TLIS

New England Capital Financial Advisors’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

New England Capital Financial Advisors’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$6 – 414
2023
Q3 		$6 Hold
1
– – ﹤0.01% 395
2023
Q2 		$5 Hold
1
– – ﹤0.01% 391
2023
Q1 		$5 Hold
1
– – ﹤0.01% 436
2022
Q4 		$6 Buy
+1
New +$6 ﹤0.01% 441